PULSE BIOSCIENCES, INC. (PLSE)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

-800K 0 800K 1.6M 2.4M Q2 '22: 2.1M Q3 '22: 1.6M Q4 '22: 700K Q1 '23: 256K Q2 '23: -9K Q3 '23: -9K Q4 '23: 0 Q1 '24: 0 Q2 '24: 0 Q3 '24: 0 Q4 '24: 0 Q1 '25: 0 Q2 '25: 0 Q3 '25: 86K Q4 '25: 350K Q1 '26: 751K Q2 '26: 1.2M Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

-12M -8M -4M 0 4M 8M 12M Q2 '22: -2.1M Q3 '22: -10.3M Q4 '22: -11.2M Q1 '23: -10.8M Q2 '23: -9.7M Q3 '23: -1.3M Q4 '23: 0 Q2 '25: 0 Q3 '25: -193K Q4 '25: -189K Q1 '26: -158K Q2 '26: 3K Q3 '22 Q1 '23 Q3 '23 Q2 '25 Q4 '25 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

-90M -60M -30M 0 30M 60M 90M Q4 '15: -4.5M Q1 '16: -5.4M Q2 '16: -6.7M Q3 '16: -8.2M Q4 '16: -9.5M Q1 '17: -11M Q2 '17: -15M Q3 '17: -19.7M Q4 '17: -25.6M Q1 '18: -31M Q2 '18: -34M Q3 '18: -37.3M Q4 '18: -37.5M Q1 '19: -39M Q2 '19: -41.2M Q3 '19: -42.1M Q4 '19: -47M Q2 '21: -60M Q3 '21: -61.4M Q4 '21: -63M Q1 '22: -61.8M Q2 '22: -61M Q3 '22: -64.7M Q4 '22: -58.1M Q1 '23: -50.3M Q2 '23: -46.6M Q3 '23: -39.8M Q4 '23: -43.6M Q1 '24: -44.6M Q2 '24: -46.1M Q3 '24: -48.5M Q4 '24: -56.3M Q1 '25: -63.7M Q2 '25: -72.2M Q3 '25: -78.9M Q4 '25: -76.9M Q1 '26: -78M Q2 '26: -83M Q2 '16 Q3 '17 Q4 '18 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

-90M -60M -30M 0 30M 60M 90M Q4 '15: -2.8M Q1 '16: -4.1M Q2 '16: -5.7M Q3 '16: -7.7M Q4 '16: -9.5M Q1 '17: -11M Q2 '17: -15M Q3 '17: -19.7M Q4 '17: -25.6M Q1 '18: -31M Q2 '18: -34M Q3 '18: -37.3M Q4 '18: -37.5M Q1 '19: -39M Q2 '19: -41.2M Q3 '19: -42.1M Q4 '19: -47M Q1 '20: -48.8M Q2 '20: -48.7M Q3 '20: -49.9M Q4 '20: -49.9M Q1 '21: -56.6M Q2 '21: -60.6M Q3 '21: -62M Q4 '21: -63.7M Q1 '22: -62.3M Q2 '22: -61M Q3 '22: -64.7M Q4 '22: -58.5M Q1 '23: -51M Q2 '23: -46.9M Q3 '23: -39.5M Q4 '23: -42.2M Q1 '24: -42.5M Q2 '24: -44M Q3 '24: -46.1M Q4 '24: -53.6M Q1 '25: -60.2M Q2 '25: -68M Q3 '25: -74.7M Q4 '25: -72.8M Q1 '26: -74.6M Q2 '26: -80.1M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Cost of Revenue TTM

0 5M 10M 15M Q2 '22: 4.2M Q3 '22: 11.9M Q4 '22: 11.9M Q1 '23: 11M Q2 '23: 9.7M Q3 '23: 1.3M Q4 '23: 0 Q2 '25: 0 Q3 '25: 279K Q4 '25: 539K Q1 '26: 909K Q2 '26: 1.2M Q3 '22 Q1 '23 Q3 '23 Q2 '25 Q4 '25 Q2 '26

Operating Cash Flow TTM

-75M -50M -25M 0 25M 50M 75M Q4 '15: -3.3M Q1 '16: -4.3M Q2 '16: -6M Q3 '16: -7.1M Q4 '16: -8.1M Q1 '17: -9.1M Q2 '17: -8M Q3 '17: -9.4M Q4 '17: -11.1M Q1 '18: -13.6M Q2 '18: -18.1M Q3 '18: -21.6M Q4 '18: -23.9M Q1 '19: -26.2M Q2 '19: -30.2M Q3 '19: -31.3M Q4 '19: -34.2M Q1 '20: -36.5M Q2 '20: -34.7M Q3 '20: -35.3M Q4 '20: -35.4M Q1 '21: -37.4M Q2 '21: -45.9M Q3 '21: -50.7M Q4 '21: -54.1M Q1 '22: -58M Q2 '22: -54.5M Q3 '22: -51.7M Q4 '22: -47M Q1 '23: -38M Q2 '23: -34.4M Q3 '23: -34.2M Q4 '23: -33M Q1 '24: -36.3M Q2 '24: -35.4M Q3 '24: -34M Q4 '24: -36.3M Q1 '25: -40.1M Q2 '25: -44.5M Q3 '25: -48.5M Q4 '25: -54.1M Q1 '26: -55.2M Q2 '26: -61.1M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Free Cash Flow TTM

-75M -50M -25M 0 25M 50M 75M Q2 '16: -6.1M Q3 '16: -7.1M Q4 '16: -8.1M Q2 '18: -18.4M Q3 '18: -21.9M Q4 '18: -24.2M Q1 '19: -26.5M Q2 '19: -30.4M Q3 '19: -32M Q4 '20: -35.8M Q1 '21: -37.8M Q2 '21: -46.3M Q3 '21: -51.2M Q4 '21: -54.5M Q1 '22: -58.7M Q2 '22: -55M Q3 '22: -52.2M Q4 '22: -47.4M Q1 '23: -38.1M Q2 '23: -34.5M Q3 '23: -34.3M Q4 '23: -33.2M Q1 '24: -36.3M Q2 '24: -35.5M Q3 '24: -34.1M Q4 '24: -36.5M Q1 '25: -40.2M Q2 '25: -44.7M Q3 '25: -48.8M Q4 '25: -54.4M Q1 '26: -55.5M Q2 '26: -61.4M Q2 '18 Q2 '19 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q2 '21: 26.5M Q3 '21: 29.6M Q1 '22: 29.7M Q2 '22: 31.5M Q3 '22: 37.2M Q1 '23: 37.4M Q2 '23: 46.1M Q3 '23: 56.9M Q1 '24: 57.1M Q2 '24: 57.2M Q3 '24: 61.1M Q1 '25: 67.1M Q2 '25: 67.3M Q3 '25: 67.4M Q1 '26: 68M Q2 '26: 69.2M Q3 '21 Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.40 -1.60 -0.80 0.00 0.80 1.60 2.40 Q4 '15: -0.37 Q1 '16: -0.53 Q2 '16: -0.68 Q3 '16: -0.79 Q4 '16: -0.87 Q1 '17: -0.88 Q2 '17: -1.08 Q3 '17: -1.39 Q4 '17: -1.71 Q1 '18: -1.99 Q2 '18: -2.10 Q3 '18: -2.22 Q4 '18: -2.20 Q1 '19: -2.18 Q2 '19: -2.19 Q3 '19: -2.12 Q4 '19: -2.27 Q1 '20: -2.35 Q2 '20: -2.33 Q3 '20: -2.27 Q4 '20: -2.15 Q1 '21: -2.29 Q2 '21: -2.34 Q3 '21: -2.31 Q4 '21: -2.29 Q1 '22: -2.16 Q2 '22: -2.02 Q3 '22: -2.03 Q4 '22: -1.73 Q1 '23: -1.41 Q2 '23: -1.19 Q3 '23: -0.89 Q4 '23: -0.88 Q1 '24: -0.80 Q2 '24: -0.78 Q3 '24: -0.80 Q4 '24: -0.91 Q1 '25: -0.98 Q2 '25: -1.06 Q3 '25: -1.14 Q4 '25: -1.08 Q1 '26: -1.10 Q2 '26: -1.18 Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.